Nanomedicine News

RSS

Novavax Begins Enrollment in Phase 2 Clinical Trial of RSV F Nanoparticle Vaccine

Novavax, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that enrollment has begun in a Phase 2 clinical trial of its respiratory syncytial virus (RSV) F-protein nanoparticle vaccine candidate (RSV F Vaccine), in healthy elderly subjects.

From Novavax Inc. 15 Oct 2014

Enhanced Red-Emission Nanoparticles Combined with Photodynamic Drug Therapy Kills Malignant Cells

An international group of scientists led by Gang Han, PhD, has combined a new type of nanoparticle with an FDA-approved photodynamic therapy to effectively kill deep-set cancer cells in vivo with minimal damage to surrounding tissue and fewer side effects than chemotherapy. This promising new treatment strategy could expand the current use of photodynamic therapies to access deep-set cancer tumors.

15 Oct 2014

Nano-Optics Researchers Develop Light-Based Sensor for Blood Analysis

The development is based on optical principles and provides precision and allows saving vital time for the patient.

15 Oct 2014

UCI Receives NSF Grant to Further Develop Nano-Optical Sensor for Detecting Infection in Breath

Imagine a low-cost, disposable breath analysis device that a person with cystic fibrosis could use at home along with a smartphone to immediately detect a lung infection, much like the device police use to gauge a driver's blood alcohol level.

15 Oct 2014

Alnylam Presents Clinical Data for Patisiran Phase II OLE Study for Familial Amyloidotic Polyneuropathy

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, today reported that Alnylam Pharmaceuticals, Inc. presented six-month clinical data for the ongoing Patisiran Phase II Open Label Extension (OLE) study in patients with Familial Amyloidotic Polyneuropathy (FAP).

15 Oct 2014

Nanoscale DNA Cocoons Target Cancer Cells

Biomedical engineering researchers have developed a drug delivery system consisting of nanoscale “cocoons” made of DNA that target cancer cells and trick the cells into absorbing the cocoon before unleashing anticancer drugs. The work was done by researchers at North Carolina State University and the University of North Carolina at Chapel Hill.

14 Oct 2014

Onxeo Receives Second Payment from BPIFrance for Support of Nano Innovation for Cancer Consortium

Onxeo S.A. (Euronext Paris, NASDAQ OMX Copenhagen: ONXEO), an innovative biopharmaceutical company specialized in the development of orphan oncology drugs, today announces the second payment of €1.25 million from BPIFrance (ex OSEO) as a part of the funding granted to support the NICE (Nano Innovation for Cancer) consortium.

13 Oct 2014

Scientists Identify Key Characteristics That Enhance Nanoparticle’s Ability to Penetrate Skin

Scientists at the University of Southampton have identified key characteristics that enhance a nanoparticle's ability to penetrate skin, in a milestone study which could have major implications for the delivery of drugs.

10 Oct 2014

Aciex Awarded US Patent for Novel Nanocrystalline Formulations of Fluticasone Propionate

Aciex Therapeutics, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued a U.S. Patent (No. 8,829,005) covering AC-170 Cetirizine Ophthalmic Compositions and a U.S. Patent (No. 8,765,725) covering AC-155 Fluticasone Propionate Nano-crystalline Compositions.

9 Oct 2014

MJR PharmJet Wins Award for Technology That Enables Increased Drug Loading of Hydrophobic Nanoparticles

CPhI Worldwide, organised by UBM Live, announced the winners of the 11th annual CPhI live Pharma Awards. The annual awards showcase outstanding developments and innovations from the pharma industry's most dynamic and progressive players.

9 Oct 2014

Nanomedicine News

Novavax Begins Enrollment in Phase 2 Clinical Trial of RSV F Nanoparticle Vaccine

Enhanced Red-Emission Nanoparticles Combined with Photodynamic Drug Therapy Kills Malignant Cells

Nano-Optics Researchers Develop Light-Based Sensor for Blood Analysis

UCI Receives NSF Grant to Further Develop Nano-Optical Sensor for Detecting Infection in Breath

Alnylam Presents Clinical Data for Patisiran Phase II OLE Study for Familial Amyloidotic Polyneuropathy

Nanoscale DNA Cocoons Target Cancer Cells

Onxeo Receives Second Payment from BPIFrance for Support of Nano Innovation for Cancer Consortium

Scientists Identify Key Characteristics That Enhance Nanoparticle’s Ability to Penetrate Skin

Aciex Awarded US Patent for Novel Nanocrystalline Formulations of Fluticasone Propionate

MJR PharmJet Wins Award for Technology That Enables Increased Drug Loading of Hydrophobic Nanoparticles

Combining Nanofluids and Turbulators for Sustainable Energy

Enhancing Material Properties through Nanotube Encapsulation

Sustainable Carbon Nanomaterial Gii Set to Transform Energy Storage in Internet of Things Devices

Brain-Inspired Nano-Tech Promises New Era for Electronics

Breakthrough in 2D Material Growth Opens Doors to Cleaner Energy and Next-Generation Technology

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials